SiteOne Therapeutics competitors
SiteOne Therapeutics's competitors include Relay Therapeutics, Biohaven Pharmaceutical, Enanta Pharmaceuticals and CEL-SCI
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  SiteOne Therapeutics SiteOne Therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids |  Relay Therapeutics Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities. |  Biohaven Pharmaceutical Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system. |  Enanta Pharmaceuticals Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs. |  CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |
Founding Date | Founding Date 2010 | Founding Date 2016 | Founding Date 2014 | Founding Date 1998 | Founding Date 1983 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Bozeman, US HQ | Locations Cambridge, US HQ | Locations New Haven, US HQ | Locations Watertown, US HQ | Locations Vienna, US HQ |
Employees | Employees N/A | Employees 642% increase | Employees 574% increase | Employees 8917% increase | Employees 43 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) 23 m |
Financial ⚠ | |||||
Net income | Net income N/A | Net income N/A | Net income N/A | Net income $17.7m (FY, 2017) | Net income ($14.4m) (FY, 2017) |
Funding | |||||
Latest funding round | Latest funding round $ 15m (over 1 year ago) | Latest funding round $ 63m (8 months ago) | Latest funding round $ 80m (almost 2 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 17.8m | Total funding raised $ 120m | Total funding raised $ 80m | Total funding raised $ 9.2m | Total funding raised N/A |
For sources of this data, please see the company profileDownload Excel
View company profiles
Relay Therapeutics
HQ
Cambridge, US
Employees
64↑ 2% increase
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
View companyBiohaven Pharmaceutical
HQ
New Haven, US
Employees
57↑ 4% increase
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
View companyEnanta Pharmaceuticals
HQ
Watertown, US
Employees
89↑ 17% increase
Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs.
View companyCEL-SCI
HQ
Vienna, US
Employees
43
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View company